134 related articles for article (PubMed ID: 22752887)
1. Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane.
Jang SI; Kim JH; Kim M; Yang S; Jo EA; Lee JW; Na K; Kim JM; Jeong S; Lee DH; Lee DK
Endoscopy; 2012 Sep; 44(9):825-31. PubMed ID: 22752887
[TBL] [Abstract][Full Text] [Related]
2. Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract.
Jang SI; Jeong S; Lee DH; Na K; Yang S; Lee DK
Gut Liver; 2019 Apr; 13(4):471-478. PubMed ID: 30970427
[TBL] [Abstract][Full Text] [Related]
3. Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model.
Lee SS; Shin JH; Han JM; Cho CH; Kim MH; Lee SK; Kim JH; Kim KR; Shin KM; Won YH; Song HY
Gastrointest Endosc; 2009 May; 69(6):1140-7. PubMed ID: 19243763
[TBL] [Abstract][Full Text] [Related]
4. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane.
Lee DK; Kim HS; Kim KS; Lee WJ; Kim HK; Won YH; Byun YR; Kim MY; Baik SK; Kwon SO
Gastrointest Endosc; 2005 Feb; 61(2):296-301. PubMed ID: 15729251
[TBL] [Abstract][Full Text] [Related]
5. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
Suk KT; Kim JW; Kim HS; Baik SK; Oh SJ; Lee SJ; Kim HG; Lee DH; Won YH; Lee DK
Gastrointest Endosc; 2007 Oct; 66(4):798-803. PubMed ID: 17905025
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study.
Song TJ; Lee SS; Yun SC; Park DH; Seo DW; Lee SK; Kim MH
Gastrointest Endosc; 2011 Apr; 73(4):727-33. PubMed ID: 21288514
[TBL] [Abstract][Full Text] [Related]
7. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
[TBL] [Abstract][Full Text] [Related]
8. Nonvascular drug-eluting stent coated with sodium caprate-incorporated polyurethane for the efficient penetration of paclitaxel into tumor tissue.
Jeong D; Lee DH; Lee DK; Na K
J Biomater Appl; 2015 Mar; 29(8):1133-44. PubMed ID: 25252589
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a Multiplex Paclitaxel Emission Stent Using a Pluronic
Jang SI; Lee SJ; Jeong S; Lee DH; Kim MH; Yoon HJ; Lee DK
Gut Liver; 2017 Jul; 11(4):567-573. PubMed ID: 28335102
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction.
Shim CS; Lee YH; Cho YD; Bong HK; Kim JO; Cho JY; Kim YS; Lee JS; Lee MS; Hwang SG; Shin KM
Endoscopy; 1998 May; 30(4):345-50. PubMed ID: 9689506
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study.
Jang SI; Lee KT; Choi JS; Jeong S; Lee DH; Kim YT; Lee SH; Yu JS; Lee DK
Endoscopy; 2019 Sep; 51(9):843-851. PubMed ID: 30414164
[TBL] [Abstract][Full Text] [Related]
12. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma.
Xiao JB; Weng JY; Hu YY; Deng GL; Wan XJ
World J Gastroenterol; 2020 Aug; 26(31):4589-4606. PubMed ID: 32884219
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
Büllesfeld L; Gerckens U; Müller R; Grube E
Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
[TBL] [Abstract][Full Text] [Related]
15. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model.
Wilson GJ; Polovick JE; Huibregtse BA; Poff BC
Cardiovasc Res; 2007 Nov; 76(2):361-72. PubMed ID: 17716637
[TBL] [Abstract][Full Text] [Related]
16. Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries.
Llano R; Winsor-Hines D; Patel DB; Seifert PS; Hamamdzic D; Wilson GJ; Wang H; Keane MG; Huibregtse BA; Wilensky RL
Circ Cardiovasc Interv; 2011 Oct; 4(5):438-46. PubMed ID: 21972400
[TBL] [Abstract][Full Text] [Related]
17. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
18. Local paclitaxel delivery after coronary stenting in an experimental animal model.
Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety evaluation of paclitaxel-loaded metal stents in patients with malignant biliary obstructions.
Yuan T; Zhu Y; Wang X; Cui W; Cao J
Eur J Surg Oncol; 2019 May; 45(5):816-819. PubMed ID: 30389299
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
